FOXM1: From cancer initiation to progression and treatment

被引:332
|
作者
Koo, Chuay-Yeng [1 ]
Muir, Kyle W. [1 ]
Lam, Eric W. -F. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London W12 0NN, England
关键词
FOXM1; Chemotherapy; Cancer; Function; Regulation; M1 TRANSCRIPTION FACTOR; BREAST-CANCER; CELL-PROLIFERATION; OXIDATIVE STRESS; UP-REGULATION; HEPATOCELLULAR CARCINOMAS; NUCLEAR TRANSLOCATION; MULTIDRUG-RESISTANCE; DOWNSTREAM TARGET; HEPATOCYTE ENTRY;
D O I
10.1016/j.bbagrm.2011.09.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Forkhead box protein M1 (FOXM1) transcription factor is a regulator of myriad biological processes, including cell proliferation, cell cycle progression, cell differentiation, DNA damage repair, tissue homeostasis, angiogenesis and apoptosis. Elevated FOXM1 expression is found in cancers of the liver, prostate, brain, breast, lung, colon, pancreas, skin, cervix, ovary, mouth, blood and nervous system, suggesting it has an integral role in tumorigenesis. Recent research findings also place FOXM1 at the centre of cancer progression and drug sensitivity. In this review the involvement of FOXM1 in various aspects of cancer, in particular its role and regulation within the context of cancer initiation, progression, and cancer drug response, will be summarised and discussed. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:28 / 37
页数:10
相关论文
共 50 条
  • [21] FOXM1 predicts disease progression in non-muscle invasive bladder cancer
    Sebastien Rinaldetti
    Ralph Wirtz
    Thomas Stefan Worst
    Arndt Hartmann
    Johannes Breyer
    Lars Dyrskjot
    Philipp Erben
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1701 - 1709
  • [22] Regulation of the master regulator FOXM1 in cancer
    Guo-Bin Liao
    Xin-Zhe Li
    Shuo Zeng
    Cheng Liu
    Shi-Ming Yang
    Li Yang
    Chang-Jiang Hu
    Jian-Ying Bai
    Cell Communication and Signaling, 16
  • [23] Analyses of FOXM1 isoforms in ovarian cancer
    Altadill, Tatiana
    Rigau, Marina
    Majem, Blanca
    Lanau, Lucia
    Castellv, Josep
    Garcia, Angel
    Perez-Benavente, Assumpcio
    Luis Sanchez, Jose
    Cabrera, Silvia
    Xercavins, Jordi
    Maria del Campo, Josep
    Gil-Moreno, Antonio
    Llaurado, Marta
    Reventos, Jaume
    CLINICAL CANCER RESEARCH, 2013, 19
  • [24] Regulation of the master regulator FOXM1 in cancer
    Liao, Guo-Bin
    Li, Xin-Zhe
    Zeng, Shuo
    Liu, Cheng
    Yang, Shi-Ming
    Yang, Li
    Hu, Chang-Jiang
    Bai, Jian-Ying
    CELL COMMUNICATION AND SIGNALING, 2018, 16
  • [25] FOXM1 As a Potential Target in Pancreatic Cancer
    Halasi, Marianna
    Gartel, Andrei L.
    GASTROENTEROLOGY, 2014, 146 (05) : S277 - S277
  • [26] Targeting FOXM1
    Myatt, Stephen S.
    Lam, Eric W. -F.
    NATURE REVIEWS CANCER, 2008, 8 (03) : 244 - 244
  • [27] Targeting FOXM1
    Stephen S. Myatt
    Eric W.-F. Lam
    Nature Reviews Cancer, 2008, 8 : 242 - 242
  • [28] FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
    Zhang, Zhenwang
    Li, Mengxi
    Sun, Tian
    Zhang, Zhengrong
    Liu, Chao
    BIOMOLECULES, 2023, 13 (05)
  • [29] Novel functions of FoxM1: from molecular mechanisms to cancer therapy
    Alvarez-Fernandez, Monica
    Medema, Rene H.
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [30] Targeting FoxM1 in ATL cells: application of FoxM1 inhibitor, thiostrepton
    Nakano, Kazumi
    Yamamoto, Naoka
    Tanabe, Aki
    Nakakido, Makoto
    Utsunomiya, Atae
    Tsumoto, Kohei
    Watanabe, Toshiki
    Uchimaru, Kaoru
    CANCER SCIENCE, 2018, 109 : 1238 - 1238